Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the efficacy and safety of Rencofilstat in subjects with nonalcoholic steatohepatitis and advanced liver fibrosis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Rencofilstat (rencofilstat)

Snippet

Sponsor: Hepion Pharmaceuticals, Inc. | Conditions: Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver | Phase 2 | Status: ACTIVE_NOT_RECRUITING